Thursday News
November 20, 2008
John Tomera joined WorldCare Clinical (WCC) as director of regulatory affairs and associate medical director. Tomera will be responsible for the management of all quality assurance and regulatory affairs operations. He will also be responsible for providing medical expertise to WCC project teams and acting as WCC’s liaison to its network of medical consultants at Massachusetts General…more...
Tuesday News
November 18, 2008
PharmaVigilant announced a four-week launch for an electronic data capture (EDC) system to support a phase 1-2 oncology trial sponsored by Threshold Pharmaceuticals. The process included 50 case report forms (CRF) and 6 different CRF books. “We chose PharmaVigilant based upon their track record, positive references, and straight-forward cost structure.” said Stew Kroll, Threshold’s VP of biostatistics…more...
Monday News
November 17, 2008
Industry campaign contributors are nudging Barack Obama to select Janet Woodcock as the next FDA head. The pitch is that she’ll guarantee continuity. Other candidates include the FDA’s own Frank Torti; Steven Nissen of the Cleveland Clinic; George Washington University professor Susan Wood; and Joshua Sharfstein, a city official in Baltimore, Maryland, who formerly worked for a…more...
Friday News
November 14, 2008
The Society for Clinical Data Management launched a new area of its website to facilitate training. Its education portal offers a self-assessment to prepare for the organization’s certification exam; tips for forming study groups; reference materials and links to the SCDM bookstore at Amazon.com; and other educational resources, including information about upcoming webinars and workshops.
WuXi PharmaTech…more...
Thursday News
November 13, 2008
Spherix said patient recruitment for a phase III trial of a diabetes drug, Naturlose, has begun in India. The company hopes to find 300 patients at 35 sites. “We believe that the Phase III trial will be completed on schedule as reported during the May 2008 annual shareholders meeting,” said Randy Brown, chief of operations. Here’s the…more...
Wednesday News
November 12, 2008
SciQuest has received two awards. Triangle Business Journal picked the company for its best places to work. And PricewaterhouseCoopers selected the firm for its Fast 50 list. “Our outstanding workforce is at the heart of every success and recognition that SciQuest receives,” said Stephen Wiehe, SciQuest president and CEO. “Our employees’ dedication to providing our customers with…more...
Tuesday News
November 11, 2008
DataTrak, a Cleveland, Ohio provider of electronic data capture (EDC) technology, reported improving quarterly financial results. Revenue rose 11 percent to $2.4 million. The net loss narrowed to $1.6 million from more than twice that amount. But the company has a limited amount of cash on hand. “Our third quarter results are an encouraging improvement and they…more...
Friday News
November 07, 2008
Patient diary firm PHT reported strong third quarter demand for its electronic patient-reported outcome (ePRO) products, calling the recent quarter one of the most successful in its history. The privately held company did not release any numbers. But the company said new trials involve nearly 4,000 patients worldwide. “PHT continues to set the global standard in ePRO…more...
November 21, 2008
Friday News
Bulletins on PHT, Kika Medical, Premier Research Group, Crichton, Sarah Cannon Research Institute (SCRI), OmniComm, CTI, Oracle, and Bio-Imaging.
Thursday News
Bulletins on Obama, Nextrials, AstraZeneca, outsourcing contracts, Tufts and Kendle.
Wednesday News
Bulletins on OmniComm, Tripos, Pharsight, InVivo Therapeutics, AstraZeneca, M.D. Anderson Cancer Center, PPD, FDA, AMA and HCNN.
Tuesday News
Bulletins on Pharm-Olam, Parexel, Bio-Quant, Irvine Pharmaceutical, GCPj, Glenmark and Wolters Kluwer.
Thursday News
Bulletins on Medidata, ECRFPlus, Spacelabs, PharmaLegacy, Aperio, Chiltern, FDA, GSK and Public Citizen.
Tuesday News
A few news bulletins on CROs in Asia, AspenBio Pharma, Lab Research, Parexel Consulting and Eli Lilly
